Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: Circ Cardiovasc Qual Outcomes. 2021 Nov 15;14(12):e008381. doi: 10.1161/CIRCOUTCOMES.121.008381

Figure 4.

Figure 4.

Percentage of metformin-prescribing clinicians who also prescribed sodium-glucose cotransporter-2 inhibitor (SGLT2i), by specialty, over time